Cosmoceutical Research Center, Inc. – FDA 483, May 29, 2026

An FDA inspection of Cosmoceutical Research Center, Inc. in Panorama City, CA, revealed significant deficiencies in their manufacturing practices. The firm failed to perform adequate identity testing for drug product components and finished products, relying instead on supplier Certificates of Analysis without verification. Additionally, there were critical issues with equipment maintenance, cleaning procedures, and overall quality control unit oversight, indicating a systemic failure to adhere to Good Manufacturing Practices.